US group questions human embryo research, calls for rules
By DPA,
Deutsche Presse-Agentur [cites Marcy Darnovsky]
| 05. 14. 2008
A US public interest group has called for the US to set up national bioethics standards and regulations on embryonic research after a group of scientists in New York State produced a genetically-engineered embryo, dpa reported.
The Center for Genetics and Society, located in Oakland, California, said Tuesday the need for such standards was clear after the research at Cornell University was brought to light by a London newspaper over the weekend. Britain is in the process of revamping its genetic research laws.
Marcy Darnovsky of the Center for Genetics and Society told Deutsche Presse-Agentur dpa that the US urgently needs federal bioethical standards and a regulatory panel similar to those in Canada and Britain or even Germany, which has some of the most stringent rules on genetic research.
"The prospect of genetic technology being used to introduce new types of genetic inequality and social division, to create genetically-enhanced children is the core of our concern," Darnovsky said.
A brief account of the study by scientists at Cornell University was published in September 2007 in the journal Fertility and Sterility...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Émile P. Torres, Truthdig | 02.26.2026
It’s well known that Jeffrey Epstein was a super-wealthy pedophile with an extraordinary network of powerful friends: tech billionaires, politicians and academics. But few people know that he was also a transhumanist — someone who believes that we should...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Zachary Brennan, Endpoints News | 02.23.2026
The FDA is spelling out the details of a new pathway to help speed personalized cell and gene therapies to market for rare diseases.
Monday’s long-awaited draft guidance outlines the agency’s “plausible mechanism” framework, a pathway FDA Commissioner Marty Makary...